Clinical Trial

Pharmacokinetic Profiles of LY03003 and Neupro

Study Description

A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro

Phase 1, single center study to assess pharmacokinetic profiles of rotigotine after single dose of LY03003 and daily patch application of Neupro in Healthy Volunteers

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - LY03003

LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection)

Drug - Neupro 4Mg/24Hr Transdermal Patch

neupro patch

Additional Information

Official Study Title

A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine After a Single Dose of LY03003 (28 mg) Versus After a Week of Daily NEUPRO® Transdermal Patch (4 mg Every 24 Hours) in Healthy Volunteers

Clinical Trial ID

NCT03733561

ParticipAid ID

bmZ20d